Prevalence of Lower Urinary Tract Symptoms in Men Over 40 Years: A Cross-Sectional Study in Samsun

Aim: Lower urinary tract symptoms (LUTS) are a common problem in ageing men. The aim of this study was to estimate the prevalence of LUTS, as measured by the International Prostate Symptom Score (IPSS), and to establish the relationship between the IPSS and quality of life (QoL) in different age groups of men over 40 years old living in Samsun city center in northern Turkey. Materials and Methods: In all, 1860 men aged over 40 years were included in this cross-sectional study. The Turkish version of the IPSS was applied to all participants using face-to-face interview. Results: The median IPSS and QoL were 3 (1-9) and 1 (0-3), and increased from 1.0 (0-4) and 0.0 (0-1) in the fifth decade to 18.0 (12-26.5) and 4.0 (3-5) in those over 80, respectively. There were statistically significant differences between the age groups in both IPSS and QoL (P < 0.01). Of the participants, 81.3% had at least one symptom, the most prevalent of which was nocturia (71.7%). Of the respondents, 29.6% had moderate-to-severe LUTS as measured by the IPSS, and the increase in the prevalence of moderate-to-severe symptoms with age was statistically important (P < 0.001). Nocturia was found to be the strongest predictor of QoL (r2 = 0.50, P < 0.001). Conclusions: The prevalence of LUTS in Turkish elderly men is fairly high and increases with age. This finding must be considered when resources are planned for medical care. On the other hand, it seems that increased public awareness is needed to combat the adverse effects of LUTS on QoL.
Anahtar Kelimeler:

Ageing men, IPSS, LUTS

Prevalence of Lower Urinary Tract Symptoms in Men Over 40 Years: A Cross-Sectional Study in Samsun

Aim: Lower urinary tract symptoms (LUTS) are a common problem in ageing men. The aim of this study was to estimate the prevalence of LUTS, as measured by the International Prostate Symptom Score (IPSS), and to establish the relationship between the IPSS and quality of life (QoL) in different age groups of men over 40 years old living in Samsun city center in northern Turkey. Materials and Methods: In all, 1860 men aged over 40 years were included in this cross-sectional study. The Turkish version of the IPSS was applied to all participants using face-to-face interview. Results: The median IPSS and QoL were 3 (1-9) and 1 (0-3), and increased from 1.0 (0-4) and 0.0 (0-1) in the fifth decade to 18.0 (12-26.5) and 4.0 (3-5) in those over 80, respectively. There were statistically significant differences between the age groups in both IPSS and QoL (P < 0.01). Of the participants, 81.3% had at least one symptom, the most prevalent of which was nocturia (71.7%). Of the respondents, 29.6% had moderate-to-severe LUTS as measured by the IPSS, and the increase in the prevalence of moderate-to-severe symptoms with age was statistically important (P < 0.001). Nocturia was found to be the strongest predictor of QoL (r2 = 0.50, P < 0.001). Conclusions: The prevalence of LUTS in Turkish elderly men is fairly high and increases with age. This finding must be considered when resources are planned for medical care. On the other hand, it seems that increased public awareness is needed to combat the adverse effects of LUTS on QoL.
Keywords:

Ageing men, IPSS, LUTS,

___

  • 1. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia. Clinical overview and the value of diagnostic imaging in 2000. Radiol Clin North Am 2000; 38: 31-47.
  • 2. Cocket AT, Aso Y, Denis L. Recommendations of the International Consensus Committee concerning: 1. Prostate symptoms score and quality of life assessment. I: Cockett AT, Aso Y, Denis L, Murphy G, Khoury S, Abrams P et al., editors. Proceedings, The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27 - 30, 1993. Jersey, Channel Islands: Scientific Communication Internationally; 1994. pp. 553-5.
  • 3. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FDR, Fourcade R et al.; the UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik Study. BJU Int 2003; 92(4): 409-14.
  • 4. Verhamme KM, Dieleman JP, Bleumink GS, Van der Lei J, Sturkenboom MC, Artibani W et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign hyperplasia in primary care - the Triumph project. Eur Urol 2002; 42(4): 323- 8.
  • 5. Aki FT, Aygun C, Bilir N, Erkan ‹, Ozen H. Prevalence of lower urinary tract symptoms in a community-based survey of men in Turkey. Int J Urol 2003; 10: 364-70.
  • 6. Khoury S, Cockett A, Aso Y Chatelain C, Andersson L, Abrams P et al. International Consultation on Urological Diseases: a decade of progress. Prostate 2000; 45: 194-9.
  • 7. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hyperplasia in the community. Lancet 1991; 338: 469- 71.
  • 8. Sagnier PP, MacFarlene G, Richard F, Teillac P, Boyle P. Results of epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J Urol 1994; 151: 1266-70.
  • 9. Hunter DJ, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old and older. J Urol 1996; 155: 1965-70.
  • 10. Norman RW, Nickel JC, Fish D, Pickett SN. “Prostate-related symptoms” in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J Urol 1994; 74: 542-50.
  • 11. Bosch JL, Hop WC, Kirkels WJ, Schroder FH. International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75: 622-30.
  • 12. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men. BJU Int 2004; 94: 327-31.
  • 13. Perrin P, Marionneau N, Cucherat M, Taieb C. Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old. Eur Urol 2005; 48(4): 601-7.
  • 14. Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001; 166(2): 563-8.
  • 15. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ et al. The prevalence of prostatism: a populationbased survey of urinary symptoms. J Urol 1993; 150: 85-9.
  • 16. Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score. Int J Urol 1997; 3: 440-6.
  • 17. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol 1998; 33: 17-21.
  • 18. Arvind PG, Mahesh RD, Mihir MD, Kishor DW, Sharad DB. Natural history of lower urinary tract symptoms: preliminary report from a community-based Indian study. BJU Int 2004; 94: 332-4.
  • 19. Sagnier PP, Girman CJ, Garraway M, Kumamoto Y, Lieber MM, Richard F et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29(1): 15-20.
  • 20. Trueman P, Hood SC, Nayak USL, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410-5
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Anesthesia for an Adult Patient with Congenital Diaphragmatic Eventration

Hülya BAŞAR, Solmaz GÜNAL, Hale Yarkan UYSAL, Ahmet Ş. UYAR

Is There a Correlation Between Extroversion Personality Characteristics of Medical Students and Awareness of Works of Art?

Dilek ASLAN, İskender SAYEK, Musacide Zehra ORDULU, Sare ALKAN, Yiğit SEZER, Emin SOYER

Diagnostic Performance of QUS for Identifying Osteoporosis in Postmenopausal Turkish Women

Güzel DİŞÇİGİL, Cengiz CEYLAN, Ayfer GEMALMAZ

Quality Assurance Standards Task Force Global Standards: Route for Accreditation in Medical Education in Europe

Hans KARLE, İskender SAYEK

Plasma Thrombin Activitable Fibrinolysis Inhibitor Levels in Behçet´s Disease

Mehmet Ali ÖZCAN, Servet AKAR, İnci ALACACIOĞLU, Özden PİŞKİN

A Real-Time Transthoracic Echocardiographic Imaging of Pulmonary Embolism in a Patient with Suspected Primary Antiphospholipid Syndrome

Mehmet Cengiz ÇOLAK, Hasan KOCATÜRK, Sebahattin ATEŞAL, Mustafa YILMAZ, Ednan BAYRAM

Interleukin-6 and Nitric Oxide Levels in Neonatal Sepsis

Esra ÖNAL, Deniz ERBAŞ, Yıldız ATALAY, Canan TÜRKYILMAZ, Ebru ERGENEKON, Murat ÖKTEM, Anıl Aktaş TAPISIZ, Kıvılcım GÜCÜYENER, Nihal DEMİREL

Prevalence of Lower Urinary Tract Symptoms in Men Over 40 Years: A Cross-Sectional Study in Samsun

Sevgi CANBAZ, Cihat DÜNDAR, Şennur DABAK, Yıldız PEKŞEN, Ahmet Tevfik SÜNTER

Genetic Variants Account for Differences in Responses in Blood Pressure and Blood Flow Values to Laryngoscopy/Intubation/Extubation

Fatma Belgin ATAÇ, Feride İffet ŞAHİN, Hülya GÖNEN, Ayşe Canan YAZICI, Zeynep KAYHAN

Plasma thrombin activatable fibrinolysis inhibitor levels in Behçet’s disease

Şebnem ÖZKAN, Fatoş ÖNEN, Bülent ÜNDAR, Faize YÜKSEL, Fatih DEMİRKAN, İnci ALACACIOĞLU, Güner Hayri ÖZSAN, Mehmet Ali ÖZCAN, Özden PİŞKİN, Oğuz GÜRLER, Nurullah AKKOÇ, Servet AKAR